FDA NDC Directory · JSON-LD · Markdown

ONDANSETRON

NDC 61919-986 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerDirect Rx
Marketing categoryAbbreviated NDA (generic) · App ANDA090469
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20140101
Package count2

External sources

Source: openFDA. Public-domain (CC0).